143 related articles for article (PubMed ID: 33759519)
21. Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice.
Agbor-Enoh S; Seudieu C; Davidson E; Dritschilo A; Jung M
Antimicrob Agents Chemother; 2009 May; 53(5):1727-34. PubMed ID: 19223622
[TBL] [Abstract][Full Text] [Related]
22. 3-alkylthio-1,2,4-triazine dimers with potent antimalarial activity.
Ban K; Duffy S; Khakham Y; Avery VM; Hughes A; Montagnat O; Katneni K; Ryan E; Baell JB
Bioorg Med Chem Lett; 2010 Oct; 20(20):6024-9. PubMed ID: 20822904
[TBL] [Abstract][Full Text] [Related]
23. Expeditious synthesis and biological evaluation of novel 2,N6-disubstituted 1,2-dihydro-1,3,5-triazine-4,6-diamines as potential antimalarials.
Gravestock D; Rousseau AL; Lourens AC; Moleele SS; van Zyl RL; Steenkamp PA
Eur J Med Chem; 2011 Jun; 46(6):2022-30. PubMed ID: 21420762
[TBL] [Abstract][Full Text] [Related]
24. The antimalarial activity of N-benzyl-oxydihydrotriazines. IV. The development of resistance to BRL 6231 (4,6-diamino-1,2-dihyydro-2-,2-dimethyl-1-(2,4,5-trichloropropyloxy)-1,3,5 triazine hydrochloride) by Plasmodium berghei.
Knight DJ; Williamson P
Ann Trop Med Parasitol; 1982 Feb; 76(1):9-14. PubMed ID: 7044325
[No Abstract] [Full Text] [Related]
25. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
[TBL] [Abstract][Full Text] [Related]
26. Antimalarial benzoheterocyclic 4-aminoquinolines: Structure-activity relationship, in vivo evaluation, mechanistic and bioactivation studies.
Ongarora DS; Strydom N; Wicht K; Njoroge M; Wiesner L; Egan TJ; Wittlin S; Jurva U; Masimirembwa CM; Chibale K
Bioorg Med Chem; 2015 Sep; 23(17):5419-32. PubMed ID: 26264839
[TBL] [Abstract][Full Text] [Related]
27. Antimalarial activities of some 3,5-diamino-as-triazine derivatives.
Rees RW; Russell PB; Foell TJ; Bright RE
J Med Chem; 1972 Aug; 15(8):859-61. PubMed ID: 5044307
[No Abstract] [Full Text] [Related]
28. Ketotifen is an antimalarial prodrug of norketotifen with blood schizonticidal and liver-stage efficacy.
Milner E; Sousa J; Pybus B; Auschwitz J; Caridha D; Gardner S; Grauer K; Harris E; Hickman M; Kozar MP; Lee P; Leed S; Li Q; Melendez V; Moon J; Ngundam F; O'Neil M; Parriott S; Potter B; Sciotti R; Tangteung A; Dow GS
Eur J Drug Metab Pharmacokinet; 2012 Mar; 37(1):17-22. PubMed ID: 22314893
[TBL] [Abstract][Full Text] [Related]
29. The antimalarial activity of N-benzyl-oxydihydrotriazines. III. The activity of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(2,4,5,-trichloropropyloxy)-1,3,5-triazine hydrobromide (BRL 51084) and hydrochloride (BRL 6231).
Knight DJ; Mamalis P; Peters W
Ann Trop Med Parasitol; 1982 Feb; 76(1):1-7. PubMed ID: 7044322
[No Abstract] [Full Text] [Related]
30. Evaluation of 4-Amino 2-Anilinoquinazolines against
Gilson PR; Nguyen W; Poole WA; Teixeira JE; Thompson JK; Guo K; Stewart RJ; Ashton TD; White KL; Sanz LM; Gamo FJ; Charman SA; Wittlin S; Duffy J; Tonkin CJ; Tham WH; Crabb BS; Cooke BM; Huston CD; Cowman AF; Sleebs BE
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559138
[TBL] [Abstract][Full Text] [Related]
31. Antimalarial activity of novel arylene bis(methylketone) compounds.
Berger BJ; Paciorkowski A; Suskin M; Dai WW; Cerami A; Ulrich P
J Infect Dis; 1996 Sep; 174(3):659-62. PubMed ID: 8769633
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery.
Quiliano M; Pabón A; Moles E; Bonilla-Ramirez L; Fabing I; Fong KY; Nieto-Aco DA; Wright DW; Pizarro JC; Vettorazzi A; López de Cerain A; Deharo E; Fernández-Busquets X; Garavito G; Aldana I; Galiano S
Eur J Med Chem; 2018 May; 152():489-514. PubMed ID: 29754074
[TBL] [Abstract][Full Text] [Related]
33. Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol.
Sato A; Hiramoto A; Morita M; Matsumoto M; Komich Y; Nakase Y; Tanigawa N; Hiraoka O; Hiramoto K; Hayatsu H; Higaki K; Kawai S; Masuyama A; Nojima M; Wataya Y; Kim HS
Parasitol Int; 2011 Sep; 60(3):270-3. PubMed ID: 21501696
[TBL] [Abstract][Full Text] [Related]
34. De novo lead optimization of triazine derivatives identifies potent antimalarials.
Shandilya A; Hoda N; Khan S; Jameel E; Kumar J; Jayaram B
J Mol Graph Model; 2017 Jan; 71():96-103. PubMed ID: 27880887
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and structure-activity relationships for new 6-fluoroquinoline derivatives with antiplasmodial activity.
Hochegger P; Faist J; Seebacher W; Saf R; Mäser P; Kaiser M; Weis R
Bioorg Med Chem; 2019 May; 27(10):2052-2065. PubMed ID: 30962114
[TBL] [Abstract][Full Text] [Related]
36. Exploration of a new type of antimalarial compounds based on febrifugine.
Kikuchi H; Yamamoto K; Horoiwa S; Hirai S; Kasahara R; Hariguchi N; Matsumoto M; Oshima Y
J Med Chem; 2006 Jul; 49(15):4698-706. PubMed ID: 16854076
[TBL] [Abstract][Full Text] [Related]
37. Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice.
de Sá MS; Costa JF; Krettli AU; Zalis MG; Maia GL; Sette IM; Câmara Cde A; Filho JM; Giulietti-Harley AM; Ribeiro Dos Santos R; Soares MB
Parasitol Res; 2009 Jul; 105(1):275-9. PubMed ID: 19367418
[TBL] [Abstract][Full Text] [Related]
38. Antimalarial activity of 1-aryl-3,3-dialkyltriazenes.
Nishiwaki K; Okamoto A; Matsuo K; Kawaguchi Y; Hayase Y; Ohba K
Bioorg Med Chem; 2007 Apr; 15(8):2856-9. PubMed ID: 17329108
[TBL] [Abstract][Full Text] [Related]
39. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Pidathala C; Amewu R; Pacorel B; Nixon GL; Gibbons P; Hong WD; Leung SC; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
J Med Chem; 2012 Mar; 55(5):1831-43. PubMed ID: 22364416
[TBL] [Abstract][Full Text] [Related]
40. 2,4-Diaminothienopyrimidines as orally active antimalarial agents.
González Cabrera D; Le Manach C; Douelle F; Younis Y; Feng TS; Paquet T; Nchinda AT; Street LJ; Taylor D; de Kock C; Wiesner L; Duffy S; White KL; Zabiulla KM; Sambandan Y; Bashyam S; Waterson D; Witty MJ; Charman SA; Avery VM; Wittlin S; Chibale K
J Med Chem; 2014 Feb; 57(3):1014-22. PubMed ID: 24446664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
